Cite
HARVARD Citation
Romanowski, B. et al. (2016). Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study. Human vaccines & immunotherapeutics. 12 (1), pp. 20-29. [Online].